Vertex Pharmaceuticals Incorporated

Registered Principal Details

Business Or Interest:
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.

Lobbying Interests:
Pharmaceutical, Medicaid and Health Issues.

CEO Name:
Jeffrey Leiden
Senior Director, Government Affairs and Public Policy

Contact
RO
Richard Olson
50 Northern Avenue
Boston, MA 20001
(617) 961-7770
Richard_Olson@vrtx.com
http://www.vrtx.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Abigail Gossman Exclusive Duties N/A Authorized On 9/21/2015 Withdrawn On N/A

Lobbying Interests

Topics Not Yet Assigned A Bill Or Rule Number

Medicaid drug coverage process and procedure.
Development, drafting or introduction of a proposal relating to
Medicaid drug coverage process and procedure.

Action Intended To Affect
Rule (by a state agency)

Notification Date
9/24/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2015
July - December
2016
January - June
2016
July - December
Total
Total Lobbying Expenditures 2015
July - December
$0.00
2016
January - June
$0.00
2016
July - December
$0.00
Total $0.00
Total Hours Communicating 2015
July - December
0.00
2016
January - June
0.00
2016
July - December
0.00
Total 0.00
Total Hours Other 2015
July - December
0.00
2016
January - June
0.00
2016
July - December
0.00
Total 0.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures